Evidence map›Paper›PMID 15293567›Full record

ArticleInternational journal of hematology2004

Two entities of precursor T-cell lymphoblastic leukemia/lymphoma based on radiologic and immunophenotypic findings.

Yasushi Onishi, Yoshihiro Matsuno, Ukihide Tateishi, Akiko Miyagi Maeshima, Masahiko Kusumoto, Takashi Terauchi, Shigeru Kusumoto, Naohiro Sekiguchi, Kazuki Tanimoto, Takashi Watanabe and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. CD56 on immune and tumor cells: what is known and beyond?Clinical and experimental immunology · 2025
    Review
  3. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  4. Immature T cell neoplasms in three young cattle.The Journal of veterinary medical science · 2016
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yasushi OnishiHematology Division, National Cancer Center Hospital, Tsukiji, Chou-ku, Tokyo, Japan.
Yoshihiro Matsuno
Ukihide Tateishi
Akiko Miyagi Maeshima
Masahiko Kusumoto
Takashi Terauchi
Shigeru Kusumoto
Naohiro Sekiguchi
Kazuki Tanimoto
Takashi Watanabe
Yukio Kobayashi
Kensei Tobinai

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) presents a mediastinal mass in one half of cases. Although the immunophenotypic features of T-ALL/LBL have been analyzed in several studies, few studies have been focused on the relationship between the anatomic distribution of lesions and immunophenotypic findings. We analyzed the clinicopathologic findings for 17 patients with T-ALL/LBL diagnosed since 1993 and whose radiologic findings were available. Data on 14 men and 3 women with a median age of 26 years (range, 10-61 years) were analyzed. On the basis of radiologic findings, the cases were divided into thymic type (n = 8) and nonthymic type (n = 9). Patients with the thymic type of T-ALL/LBL had a large mediastinal mass and minimal systemic lymphadenopathy only in the supradiaphragmatic region. Those with the non-thymic type had predominantly systemic lymphadenopathy that included infradiaphragmatic lesions. Expression of CD8 (6/7 versus 0/9) was more frequently found in the thymic type (P < .001), whereas expression of CD56 (0/7 versus 5/9) was more frequent in the nonthymic type (P = .034). In conclusion, T-ALL/LBL was divided into 2 entities, thymic type and nonthymic type, on the basis of radiologic findings and immunophenotypic features. Analysis of the expression of CD8 and CD56 would be useful for biologically classifying T-ALL/LBL into the 2 types. This study was performed in a single institution, was retrospective, and had a limited number of patients; multicenter confirmatory studies are warranted.

Indexed as

ImmunophenotypingAdolescentAdultBiopsyCD56 AntigenChildFemaleGenotypeHumansLymphoma, T-CellMaleMediastinal NeoplasmsMiddle AgedPrecursor T-Cell Lymphoblastic Leukemia-LymphomaRadiographyReceptors, Antigen, T-Cell, alpha-betaCD56 AntigenReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID15293567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.